Genetic, protein and transcription profiles of Neuromuscular Disorders

  • Research type

    Research Study

  • Full title

    Identification of genes, proteins and transcripts associated with Neuromuscular diseases.

  • IRAS ID

    141166

  • Contact name

    Francesco Muntoni

  • Contact email

    f.muntoni@ucl.ac.uk

  • Sponsor organisation

    GOSH/ UCL ICH Joint R&D Office

  • Research summary

    Childhood neuromuscular diseases (NMD) are rare and genetically heterogeneous conditions characterized by early onset weakness and disability. Examples of childhood NMD are congenital muscular dystrophies (CMD) and myopathies (CMY), for which the level of heterogeneity has exceeded our even most recent estimate, with at least 12 genes responsible for CMY and 18 genes for CMD. However, at least 50% of the patients do not carry mutations in any of these genes. Due to the unknown genetic diagnosis, a significant number of affected individuals and families are unable to take advantage of genetic counselling or anticipatory care. There are a number of therapeutic developments in cellular or animal models, but this progress is not applicable to families without a final diagnosis. \nWe intend to study DNA samples from patients without a final diagnosis in order to identify the genetic defect associated with the NMD. We will also study the transcript and protein profile in NMD patients with and without a known diagnosis, in patients with other neuromuscular disorders and normal controls to identify either primarily or secondarily altered transcripts and proteins that could also serve as biomarkers. New therapeutic approaches correcting the genetic defect or the altered pathway will be tested on cell cultures.\nWe aim to use materials (muscle, DNA, RNA, peripheral blood mononuclear cells, serum, plasma, urine, skin, cell cultures) from patients with NMD and normal controls. All tissue samples have been obtained for diagnostic, surgical, research or routine blood sampling purposes, or from normal (control) volunteers, and are stored in our research biobank. For samples collected after 01/09/2006, a specific biobank consent form, describing the possibility of using the stored samples for research purposes for neuromuscular disorders will be obtained from each patient, but some patients have been consented using a generic research consent form.

  • REC name

    East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

  • REC reference

    13/EE/0398

  • Date of REC Opinion

    10 Dec 2013

  • REC opinion

    Further Information Favourable Opinion